Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-20 2:25 pm Purchase | 2025-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 280,138 9.900% | 280,138 (New Position) | Filing History |
| 2025-04-02 4:13 pm Sale | 2025-03-31 | 13G | InMed Pharmaceuticals Inc. INM | AdvisorShares Trust | 0 0.000% | -1,833 (Position Closed) | Filing History |
| 2025-01-03 4:17 pm Purchase | 2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 36,135 4.900% | 34,823 (+2653.29%) | Filing History |
| 2024-12-18 08:05 am Purchase | 2024-12-13 | 13G | InMed Pharmaceuticals Inc. INM | YA II PN Ltd. | 80,372 9.990% | 80,372 (New Position) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 696,318 4.990% | 666,007 (+2197.27%) | Filing History |
| 2024-11-12 1:44 pm Purchase | 2024-09-30 | 13G | InMed Pharmaceuticals Inc. INM | AdvisorShares Trust | 36,665 8.770% | 36,665 (New Position) | Filing History |
| 2024-02-14 2:28 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 30,311 9.990% | 22,026 (+265.88%) | Filing History |
| 2024-01-03 5:43 pm Purchase | 2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM | SABBY MANAGEMENT LLC | 26,249 11.000% | 26,249 (New Position) | Filing History |
| 2023-02-14 12:58 pm Purchase | 2022-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Armistice Capital, LLC | 8,284 9.990% | 8,284 (New Position) | Filing History |
| 2022-02-04 3:29 pm Purchase | 2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM | Hudson Bay Capital Management LP | 1,120 3.810% | 231 (+25.99%) | Filing History |